The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas - Hormonal and mutation screening

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue 5, 2008, Pages 272-275

  Wagnerova, H ^a   Lazurova I ^a   Habalova V ^a   Dudasova D ^a   Vrzgula, A ^a  

^a University Ko ice   (Slovakia)

Author keywords

17 OH progesterone; 21 hydroxylase deficiency; Adrenal incidentalomas

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; HYDROXYPROGESTERONE; PRASTERONE; PRASTERONE SULFATE; STEROID 21 MONOOXYGENASE; TETRACOSACTIDE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CYST; ADRENAL HYPERPLASIA; ADRENAL INCIDENTALOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYP21 GENE; DIAGNOSTIC IMAGING; DNA DETERMINATION; DRUG RESPONSE; FEMALE; GENE; GENE MUTATION; GERM LINE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMAGE ANALYSIS; MALE; MUTATIONAL ANALYSIS; MYELOLIPOMA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; STEROID 21 MONOOXYGENASE DEFICIENCY;

17-ALPHA-HYDROXYPROGESTERONE; ADENOMA; ADRENAL CORTEX FUNCTION TESTS; ADRENAL GLAND NEOPLASMS; ADRENAL HYPERPLASIA, CONGENITAL; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; DNA MUTATIONAL ANALYSIS; FEMALE; GERM-LINE MUTATION; HORMONES; HUMANS; HYPERPLASIA; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; PREVALENCE; STEROID 21-HYDROXYLASE;

EID: 44849087114     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1004551     Document Type: Article

References (17)

1. Abecassis M, MacLoughlin MJ, Langer B, Kudlow JE. Serendipitous adrenal masses. Prevalence, significance and management. Am J Surg 1985; 149: 783-788
2. Avivi I, Pollack S, Gideoni O, Linn S, Blumenfeld Z. Overdiagnosis of 21 hydroxylase late onset congenital adrenal hyperplasia: correlation of corticotropin test and human leukocyte antigen typing. Fertil Steril 1996; 66: 557-563
3. Azziz R, Dewailly D, Owerbach D. Clinical review 56. Nonclassic adrenal hyperplasia: Current concepts. J Clin Endocrinol Metab 1994; 78: 810-815
4. Bernini GP, Argenio GF, Vivaldi MS, Moretti A, Miccoli P, Iaconi P, Magagna A, Salvetti A. Utility of plasma dehydroepiandrosterone sulphate determination in adrenal incidentalomas. J Endocrinol Invest 1998; 21: 365-371
5. Beuschlein F, Schulze E, Moro P, Gensheimer HP, Maser-Gluth C, Allolio B, Reincke M. Steroid 21-hydroxylase mutation and 21-hydroxylase mRNA expression in human adrenocortical tumor. J Clin Endocrinol Metab 1998; 83: 2585-2588
6. Devenyi I. Possibility of normokaliemic primary aldosteronism as reflected in the frequency of adrenal cortical adenomas. J Clin Pathol 1967; 20: 49-51
7. Jaresch S, Kornely E, Kley HK, Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab 1992; 74: 685-690
8. Hedeland H, Ostberg G, Hokfelt B. One the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 1968; 184: 211-214
9. Mancini T, Kola B, Mantero F, Arnaldi G. Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to low-dose adrenocorticotropin. J Clin Endocrinol Metab 2003; 88: 1994-1998
10. Mantero F, Arnaldi G. Investigation protocol: adrenal enlargement. Clin Endocrinol (Oxf) 1999; 50: 141-146
11. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A. A survey on Adrenal Icidentaloma in Italy. J Clin Endocrinol Metab 2000; 85: 637-644
12. Oriola J, Plensa I, Machuca I, Pavia C, Rivera-Fillat F. Rapid screening method for detecting mutations in the 21-hydroxylase gene. Clin Chem 1997; 43: 557-561
13. Pang S. The molecular and clinical spectrum of 3beta-hydroxysteroid dehydrogenase deficiency disorder. Trends Endocrinol Metab 1998; 9: 82-86
14. Patócs A, Tóth M, Barta C, Sasvári-Székely M, Varga I, Szucs N, Jakab C, Gláz E, Rácz K. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. Eur J Endocrinol 2002; 147: 349-355
15. Reincke M, Peter M, Sippel WG, Allollio B. Impairment of 11-beta-hydroxylase but not 21 hydroxylase in adrenal "incidentaloma". Eur J Endocrinol 1997; 136: 196-200
16. Rossi R, Tauchmannova L, Luciano A, Di Martino M, Battista C, Viscovo L del, Nuzzo V, Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma. Clinical and biochemical features. J Clin Endocrinol Metab 2000; 85: 1440-1448
17. Wedell A, Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum Mol Genet 1993; 2: 499-504